Olema Pharmaceuticals, Inc.

OLMA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.06+0.86%

2026-11-02

Financials

Valuation Metrics

Olema Pharmaceuticals, Inc.'s Market Cap is $617M. At end of 2025 it was $2.28B. Ranked #2655 of 3,116 in US market (top 85%), #1143 of 1,472 on NASDAQ (top 78%), #205 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$617M	US#2,655/3,116 Sec#205/265
Revenue	$0.00	US#2,859/3,116 Sec#193/265
Net Income	$-205M	US—/3,116 Sec—/265
Total Assets	$487M	US#2,768/3,116 Sec#167/265
Net Assets	$431M	US#2,312/3,116 Sec#123/265
Value
P/B	1.43x	US#881/3,116 Sec#37/265
FCF Yield	-26.71%	US—/3,116 Sec—/265
Profitability
ROE	-47.51%	US#2,661/3,116 Sec#153/265
ROA	-42.04%	US#2,951/3,116 Sec#195/265
Financial Health
Debt Ratio	13.01%	US#145/3,116 Sec#60/265
Total Debt	$660000.00	US#2,979/3,116 Sec#247/265
FCF	$-165M	US#2,742/3,116 Sec#193/265
Cash	$49M	US#2,577/3,116 Sec#225/265
Current Ratio	8.86x	US#286/3,116 Sec#85/265
Performance
1Y Return	-21.29%	US#2,282/3,116 Sec#185/265
1M Return	-14.22%	US#2,725/3,116 Sec#215/265
From 52W High	-80.53%	US#3,055/3,116 Sec#251/265
1Y MDD	-82.11%	US#3,056/3,116 Sec#250/265
Trading
Volume	876,796 shares	US#1,379/3,116 Sec#138/265
Trading Value	$6M	US#2,401/3,116 Sec#195/265
Per Share
EPS	$-2.34	US—/3,116 Sec—/265
BPS	$4.93	US#2,280/3,116 Sec#130/265